Isotopically-labeled glycans
AssigneeMomenta Pharmaceuticals, Inc.
InventorsCarlos J. Bosques, Ian Christopher Parsons, Lakshmanan Thiruneelakantapillai, Brian Edward Collins, Hetal Sarvaiya
Life of this patent
Estimating the term…
Loading patent…
AssigneeMomenta Pharmaceuticals, Inc.
InventorsCarlos J. Bosques, Ian Christopher Parsons, Lakshmanan Thiruneelakantapillai, Brian Edward Collins, Hetal Sarvaiya
Estimating the term…
The present disclosure provides methods of making isotopically-labeled glycans or a mixture of glycans (e.g., a glycan preparation) via reductive amination. Such methods are useful, for example, in the determination of the relative amounts of a glycan species present in two or more glycoprotein preparations using mass spectroscopy. In one aspect, the present disclosure provides a method of making an isotopically-labeled glycan by a glycan with an amine and an isotopically-labeled reducing agent to provide an isotopically-labeled aminated glycan. In certain embodiments, the amine is an isotopically-labeled amine.
A method of making an isotopically-labeled aminated glycan comprising reacting a glycan with an amine and an isotopically-labeled reducing agent to provide an isotopically-labeled aminated glycan.
(canceled)
10-14. (canceled)
17-21. (canceled)
A method for determining the relative amount of a glycan species in at least two different glycan preparations, comprising steps of:
24-27. (canceled)
29-34. (canceled)
(canceled)
40-48. (canceled)
51-52. (canceled)
A method of making an isotopically-labeled aminated glycan, comprising reacting a glycan with an isotopically-labeled amine and an isotopically labeled reducing agent to provide an isotopically aminated glycan.
56-57. (canceled)
Dependencies are inferred from the claim text.